Cholesterol-Slashing Drug Can Protect High-Risk Heart Patients, Study Finds – New York Times

Cholesterol-Slashing Drug Can Protect High-Risk Heart Patients, Study Finds
New York Times
Robert Johnson 51, with his twin 6-year-old daughters, Brooke, left, and Bobbi on vacation in Florida. Mr. Johnson feared dying young of a heart attack like his father. “I always felt there was a ticking time bomb in my heart,” he said. Credit Loren …
UPDATE 1-Amgen discounts cholesterol drug, but payers want moreBusiness Insider
Did Amgen's Repatha cut CV risks enough to make it cost-effective? Analysts say noFiercePharma
Amgen Tanks On Repatha Data: AnalysisSeeking Alpha
Barron’s (blog) –Investor’s Business Daily –Yahoo News –AARP News
all 112 news articles »